Gladius Meditech Profile
Key Indicators
- Authorised Capital ₹ 4.00 Cr
as on 27-10-2024
- Paid Up Capital ₹ 4.00 Cr
as on 27-10-2024
- Company Age 4 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.30 Cr
as on 27-10-2024
- Revenue -12.00%
(FY 2023)
- Profit -111.58%
(FY 2023)
- Ebitda 474.41%
(FY 2023)
- Net Worth 1488.37%
(FY 2023)
- Total Assets 58.42%
(FY 2023)
About Gladius Meditech
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.00 Cr and a paid-up capital of Rs 4.00 Cr.
The company currently has active open charges totaling ₹4.30 Cr.
Ruchi Gupta, Ashita Verma, and Sana Zaidi serve as directors at the Company.
- CIN/LLPIN
U33100UP2020PTC130462
- Company No.
130462
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Jul 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Sitapur, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Gladius Meditech?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ruchi Gupta  | Director | 25-Jul-2023 | Current |
| Ashita Verma | Director | 06-Jul-2020 | Current |
| Sana Zaidi | Director | 15-Sep-2023 | Current |
Financial Performance of Gladius Meditech.
Gladius Meditech Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 12% decrease. The company also saw a substantial fall in profitability, with a 111.58% decrease in profit. The company's net worth Soared by an impressive increase of 1488.37%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gladius Meditech?
Unlock access to Gladius Meditech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 18 May 2022 | ₹3.00 Cr | Open |
Others Creation Date: 23 Sep 2021 | ₹5.19 M | Open |
Others Creation Date: 10 Aug 2021 | ₹2.60 M | Open |
How Many Employees Work at Gladius Meditech?
Gladius Meditech has a workforce of 12 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gladius Meditech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gladius Meditech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
